Human Health in the Lunar Environment by Reynolds, Robert J.
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
122,000 135M
TOP 1%154
4,800
1Chapter
Human Health in the Lunar 
Environment
Robert J. Reynolds
Abstract
The lunar environment contains many hazards to human health, some common 
to extraterrestrial locations, some unique to the Moon. Exposures of particular 
concern are hypobaric environments, hypogravity, space radiation, and lunar dust. 
This chapter provides a brief overview of these exposures, as they represent the 
gravest threats to human health in the lunar environment (i.e., they may affect 
mortality rates) and then reviews the published studies of mortality of the original 
twenty-four lunar astronauts who visited the Moon between 1969 and 1972. The 
chapter closes with a reexamination of lunar astronaut mortality using updated 
data, including detailed discussion of the interpretation of the results.
Keywords: astronauts, mortality, cardiovascular disease, cancer, Moon
1. Introduction
Though seemingly serene, the lunar environment presents a number of hazards 
for human health, both acute and chronic. Many of these hazards are common to 
low Earth orbit (LEO) or deep space, while others are unique to the Moon. As sev-
eral national space agencies have declared their intentions for further manned lunar 
exploration and eventual colonization, it is more important than ever to understand 
the health risks involved.
This chapter provides an overview of the major hazards associated with space 
exploration in general and examines how those hazards may differ in the lunar 
environment. The number of health risks inherent in space exploration is staggering, 
necessitating that this overview be limited in breadth, covering only those risks that 
are the most serious: hypobaric syndromes, cardiovascular disease, respiratory dis-
ease, and cancers. A thorough discussion of any one of these could easily fill a chapter. 
For this reason, the review is also limited in depth, aiming to provide adequate 
context for more detailed studies of astronaut mortality related to these risks.
Next, the chapter reviews the research to date on the mortality outcomes of the origi-
nal twenty-four lunar astronauts and presents the results of an updated investigation of 
mortality among lunar astronauts, expanding upon the findings from earlier studies.
2. Environmental hazards and health outcomes in the lunar environment
2.1 Hypobaric environments
Lunar atmospheric pressure has been estimated as 3 × 10−15 bar (3 × 10−12 kPa) 
at night [1]. This presents hypobaric health risks, requiring astronauts to wear 
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space suits or be within the confines of pressurized habitats at all times. The lack 
of atmosphere on the Moon means that lunar astronauts face the constant threat of 
decompression sickness when moving between environments of differing pressure, 
and of ebullism if exposed to the lunar surface without a spacesuit [2, 3].
The danger of decompression sickness is highest for astronauts leaving a lunar 
habitation or spacecraft to perform an extra-vehicular activity (EVA) on the lunar 
surface. Spacecraft are typically pressurized to sea-level on Earth, about 101 kPa, 
whereas US spacesuits are pressurized to only approximately 30 kPa. Astronauts 
suiting up and exiting the spacecraft or habitation to the lunar surface could 
develop nitrogen bubbles in the bloodstream or in tissues as dissolved nitrogen 
condenses under the reduced pressure [2].
Ebullism occurs when bodily fluids vaporize under extremely low atmospheric 
pressure (or in vacuum). During this process the body will swell as water vapor 
forms in soft tissues and venous blood. Ebullism is but one effect of exposure to 
very low pressure; others include cessation of circulation, loss of consciousness, 
paralysis, and eventual death [3].
2.2 Hypogravity
Life on Earth exists in an environment of constant gravitational acceleration. 
This ubiquitous force has shaped the evolution of plants and animals on the planet, 
humans included. The human skeletal structure, cardiovascular system, vestibu-
lar system and other physiological characteristics have evolved to function best 
with a constant downward pull of 9.81 m/s2 (1 Earth-gravity or 1 G). Astronauts 
traveling to the Moon will instead encounter lunar gravity, which is approximately 
1/6 G. They will also spend time both in LEO and translunar space, which are 0 G or 
microgravity environments. Environments with less than 1 G of gravity may collec-
tively be referred to as hypogravity environments.
Hypogravity is directly or indirectly responsible for a number of physiological 
changes during spaceflight. One of the most important is cardiovascular decon-
ditioning. Cardiovascular deconditioning is the constellation of symptoms that 
result from weakening of the heart as a result of prolonged periods of decreased 
cardiac workload. Included among these symptoms are temporary and less serious 
symptoms such as orthostatic intolerance and reduced aerobic capacity, as well as 
the potentially more serious outcome of cardiac arrhythmia [4, 5].
Cardiovascular deconditioning during space travel is a result of the redistribu-
tion of bodily fluids that occurs under microgravity. Of particular concern is the 
redistribution of blood throughout the circulatory system. On Earth, the pull of 
gravity pools blood in the legs and feet, whereas in microgravity the cardiovascular 
system is easily able to create a more uniform distribution of blood between the 
upper and lower parts of the body. Once this distribution has been achieved (within 
hours of entering 0 G), the body perceives the increased volume of blood in the 
upper half of the body as hypervolemia, and reduces the total volume of water in 
the body to compensate. The net effect of this is a reduced workload on the heart, 
which can eventually lead to cardiac atrophy [4, 5].
Short-duration arrhythmias have been recorded on several occasions during 
spaceflight, but it is unclear if they are the result of underlying, preexisting condi-
tions or are the result of changes induced by spaceflight [6, 7]. One potential expla-
nation for these arrhythmias is the loss of potassium with the reduction of water in 
the body when adjusting to 0 G [8]. At the time of press, NASA still considers this 
an open question [7].
Since fluid shifts under reduced gravity are responsible for the cardiovascular 
changes observed in astronauts after extended stays in LEO, it is logical to assume 
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that the Moon’s reduced gravity would lead to a similar, but perhaps lesser, decon-
ditioning. A recent review examined the evidence regarding cardiopulmonary and 
other outcomes in simulated hypogravity, including simulated lunar gravity. The 
review found that several physiological measures of cardio-pulmonary efficiency 
are improved with decreasing gravity levels, and that cardiac stoke volume increases 
with decreasing gravity, similar to 0 G conditions [9]. However, it is still unknown 
the extent to which long-term exposure to lunar gravity would attenuate the cardiac 
deconditioning seen with stays in microgravity.
2.3 Space radiation
Just as life on Earth has been shaped by the Earth’s gravitational pull, it has also 
been influenced by the Earth’s radiation environment. The types of and amounts 
of radiation typically found on Earth differ from those in space. In general, the 
amount of background radiation on Earth is lower than that in space, particularly 
for cosmic radiation. As a consequence, life on Earth has evolved in an environment 
comparatively devoid of ionizing radiation, and thus is not generally resistant to it.
Ionizing radiation in outer space is primarily particulate: protons, electrons, and 
heavy atomic nuclei. Fast-moving ions may come from deep space (galactic cosmic rays, 
or GCR) or may be ejected from the Sun during a solar particle event (SPE). Protons are 
also encountered as particles ejected from the Sun as part of an SPE [10, 11]. Since the 
Moon has very little atmosphere and a weak magnetic field, the lunar surface is unpro-
tected from cosmic radiation and thus under constant bombardment from it [12].
Exposure to ionizing radiation can have effects that occur either relatively soon 
after the dose (within 24 hours to several weeks) or relatively late after the dose 
(months or even years later). The short-term effects are called acute effects, while 
those that occur later are termed late effects. For astronauts living and working on 
the Moon, there is considerable risk for both acute and late effects.
2.3.1 Acute radiation syndrome
Acute Radiation Syndrome (ARS) is the collection of health effects that occur 
after a rapid, whole-body dose of ionizing radiation. Typical effects of ARS 
include retching and vomiting, which has been observed in animal models of SPE 
irradiation at doses as low as 0.5 Gy. Hematological changes and immune system 
suppression have been observed in various irradiated animals, as has damage to 
lung tissues, impaired cardiac function, and skin damage. Finally, fatigue has been 
observed as a common outcome of acute radiation exposure, both in cancer patients 
receiving radiotherapy and in animal models of SPE radiation effects [10].
Just as for astronauts in LEO or deep space, the risk of ARS for astronauts in the 
lunar environment is greatest for astronauts who may be on EVA during an SPE, as 
they will not have the benefit of spacecraft or lunar habitat shielding [12]. Though 
the most likely risks attached to SPEs are acute effects, a SPE of sufficient size could 
prove lethal to lunar astronauts, and such events have been observed in the recent 
past [12]. Even when SPEs are not of sufficient size to be outright lethal, doses 
absorbed during an SPE could still result in an ARS episode, and would contribute 
to the risk of late effects, as detailed below.
2.3.2 Carcinogenesis and heart disease
The primary late-effect health concern from space radiation is radiation-induced 
carcinogenesis. Leukemias, breast, lung, and gastrointestinal tumors have all been 
observed after exposure to ionizing radiation on Earth, and thus it is speculated that 
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space radiation could yield similar problems, perhaps at higher rates [11, 13]. While 
there have been no reports of increased incidence of cancer among astronauts to 
date, this is likely due to insufficient radiation doses stemming from successful 
radiation control strategies as practiced by NASA, and relatively brief journeys in 
LEO or to the Moon [14, 15].
Though epidemiologists continue to surveil the astronaut population for cancer 
mortality, a growing concern is the degenerative tissue effects that space radiation 
may have on the cardiovascular system, as accumulated damage to the vasculature 
may induce heart disease [10, 16]. Recent research has failed to find any increased 
incidence of heart disease among astronauts, even when controlling for known 
cardiovascular risk factors. Instead, astronauts were found to have a much lower 
incidence of cardiovascular disease in comparison to both the US general popula-
tion and a specially matched control population [17]. Furthermore, there was no 
difference in risk between astronauts who had spaceflight experience in comparison 
to those who did not.
2.4 Lunar dust
The surface of the Moon is covered in a meters-thick layer of loose rock and fine 
dust known as lunar regolith. This substance is the result of meteorite collisions with the 
Moon breaking down exposed lunar bedrock over the course of billions of years [18]. 
The mean size of regolith dust particles from the Apollo and Luna samples are between 
60 and 80 μm, though ultra-fine particles (those with sizes measured in nanometers) 
have been documented as well [18, 19]. It is estimated that approximately 10% of the 
very fine particulate component (<10 μm) is in the respirable range [20].
Respirable particles of lunar regolith have unique properties which make them 
potentially more toxic than dusts found on Earth. Much of the fine particle regolith 
material is created by localized vaporization and fracturing when micrometeorites 
impact the lunar surface and the existing regolith material. This creates particles 
that are jagged and sharp, as well as highly chemically reactive. Without substantial 
atmosphere and weather to grind down and react with the particles, they remain 
jagged and chemically reactive [20–22]. Finally, regolith particles of respirable size 
are near-ubiquitous with nanophase iron (np-Fe0) spheres (super-fine iron dust 
with particles measured on a nanometer scale) [21]. These physical and chemical 
properties of lunar regolith make it potentially harmful for human skin, eyes, and, 
most importantly, airways.
Lunar regolith poses a respiratory health risk in much the same way that respirable 
dust on Earth does. The inhalation of respirable particles (<10 μm) into the airway 
can irritate the airway linings and bronchi, and dust may lodge in the lungs them-
selves, promoting fibrous growths. This effect may be exacerbated by hypogravity, as 
simulation studies using animals have shown differential patterns of particle deposi-
tion under reduced gravity conditions [23–25]. Because of its jagged shape, lunar dust 
adheres to spacesuits, and, during the Apollo lunar missions, became airborne inside 
the lunar and command modules after lunar surface excursions.
Exposure to silica on Earth is known to be associated with pneumoconiosis, 
increased risk of lung infection, chronic obstructive pulmonary disease, cancers of 
the airway, certain autoimmune disorders, and chronic renal disease [26]. While it 
is not known for sure, it is reasonable to assume that lunar dust would also be asso-
ciated with these conditions, since, as mentioned above, its physical and chemical 
properties make it more toxic than silica dust on Earth.
Safe human levels of exposure to lunar regolith have been estimated through 
animal studies [27, 28]. These studies have estimated the same exposure level to 
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be in the range of 0.5–1.0 mg/m3 for a 6-month lunar surface deployment. Still 
another study estimated a human no adverse effect level (NOAEL) for intermit-
tent exposure on a 6-month mission as 0.4 mg/m3 [29]. For comparison, the US 
Occupational Safety and Health Administration (OSHA) sets a time-weighted 
average permissible exposure limit (PEL) for respirable fused silica dust of 
5 mg/m3 in an 8-hour shift of work. Respirable fused silica dust currently has 
no threshold limit value, but OSHA recommends that airborne concentrations 
of respirable particles be kept below 3 mg/m3 for insoluble particles of low 
toxicity [30].
2.5 Other risks
As part of its Human Research Program (HRP), NASA maintains a list of thirty-
four health risks associated with deep space exploration [31]. Although they are 
not organized by cause, at least half of these risks are related to the environmental 
conditions reviewed here: vacuum, hypogravity, cosmic radiation, and celestial dust 
(including lunar dust). Many of the rest of the risks are comprised by categories of 
occupational hazards such as inadequate design and engineering, psychological and 
performance issues, inadequate training, and the physical hazards associated with 
EVA. Interested readers are encouraged to investigate the list published by NASA 
and learn more about these risks.
3. Mortality risk for lunar astronauts
Though humans have spent relatively little time on the lunar surface, health 
risks associated with the lunar environment are myriad. It is therefore possible that 
lunar astronauts have faced premature mortality risk because of their time in orbit 
around the Moon or on its surface. This section first reviews the existing literature 
on lunar astronaut mortality, and then updates those findings with a new original 
analysis of the data.
3.1 Prior studies of lunar astronaut mortality
Studies of lunar astronaut mortality have focused on searching for evidence of 
increased mortality due to either cancer or cardiovascular disease, either of which 
the literature suggests may be elevated with sufficient exposure to ionizing radia-
tion in outer space.
The first study to isolate lunar astronauts in a mortality analysis attempted 
to examine if a larger proportion of lunar astronauts had died of cardiovascular 
disease than might be expected given a general population comparison cohort or 
in comparison to non-lunar astronauts (including members of pre-NASA experi-
mental flight programs administered by the US Air Force) [32]. To do this however, 
the authors used a cross-sectional statistical method inappropriate to the data 
[33, 34]. This approach led the researchers to conclude, erroneously, that lunar 
astronauts had indeed experienced an excess proportion of deaths due to cardio-
vascular disease in comparison to the general population, as well as in comparison 
to astronauts who never went to space and astronauts who only flew on missions to 
low Earth orbit. A reanalysis of the data (using methods appropriate to longitudi-
nal cohort studies) told a different story: lunar astronauts were at reduced risk of 
mortality from cardiovascular disease in comparison to the general population, and 
showed no differences in risk in comparison to other groups of astronauts [34]. This 
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conclusion was further supported by a study of cardiovascular disease incidence 
which, as described above, found no increase in the incidence of cardiovascular 
disease for any astronauts [17].
A recent study of cosmic radiation exposure and mortality risk analyzed data 
from all 73 astronauts selected before 1970 [15]. The study used recorded radia-
tion doses as the exposure measurement, and looked at several cancer and CVD 
outcomes. Results indicated significant reductions in mortality risk from all 
cardiovascular disease, ischemic heart disease, all cancers, and all-cause mortality, 
even though they found a greater than five-fold increase in risk of death by external 
causes. Though this study was not exclusively of lunar astronauts, lunar astronauts 
did make up one-third of the study group. These results agree with prior studies, 
and are further suggestive of a lack of excess mortality risk in the lunar cohort from 
cancer, CVD or any other natural cause.
3.2 Updated analysis of lunar astronaut mortality
This analysis compares the mortality rate of lunar astronauts to that of all other 
NASA astronauts for several cause-of-death categories, and with follow-up through 
31 October 2018.
3.2.1 Data
Data for this analysis were those of all male NASA astronauts selected between 
1959 and 2013. As there have been no female lunar astronauts, I limited the dataset 
to males. I counted follow-up time for non-lunar astronauts as the date of selection 
until either death or 31 October 2018, whichever came first. To avoid immortal time 
bias, follow-up time for lunar astronauts was from the date of the first lunar mis-
sion until either death or 31 October 2018 [35]. A total of 314 non-lunar astronauts 
contributed 7534 person-years of observation time and 50 deaths, while the 24 
lunar astronauts contributed 1002 person-years of observation and 12 deaths.
3.2.2 Causal model
Figure 1 displays a causal diagram for astronaut mortality in the form of a 
directed acyclic graph (DAG). The diagram shows the theorized causal relation-
ship between several measured factors, unmeasured factors, and the outcome, 
mortality. In this DAG, Year has a direct effect on other potential explanatory 
variables as well as a direct effect on mortality rate. This makes Year a confounder 
of the relationship between the exposure of interest – being a lunar astronaut 
– and mortality rate. This in turn means that the paths leading from Year to 
Mortality Rate are biasing paths as well. Controlling for Year removes this con-
founding, so I included Year in all models. Similarly, Age at Selection confounds 
the relationship between being a lunar astronaut and mortality through its causal 
effect on being a lunar astronaut and on current age. I therefore adjusted for cur-
rent age in all models as well.
The circle for “other factors” represents any of an unlimited set of potential 
confounding variables that were not measured in the data. This set of unnamed 
factors are also assumed to be influenced by year of selection, and themselves 
have a causal effect on becoming a lunar astronaut as well as mortality rate. This 
makes these other factors confounders as well. However, as they are unmeasured, 
there is no way to control for any residual confounding that these factors may 
introduce.
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3.2.3 Statistical methods
To estimate if lunar astronauts have experienced higher age-specific mortality 
risk since their lunar missions, I modeled their mortality due to various causes of 
death. To do this I fit a series of Poisson regression models to discreet time-interval 
data. These data break the total follow-up period for each individual into smaller 
intervals with both fixed and time-varying covariates, including a variable contain-
ing the length of the interval and an indicator of death or survival on the interval. 
By using the log of the time on each interval as an offset, the model estimates the 
log of the mortality rate (rather than the count of deaths) as a linear function of 
the covariates. The resulting model provides mortality rate ratios (MRR) for the 
estimated parameters, which can be interpreted as relative risks of death.
I fit two sets of models for each of 4 outcomes, for 8 models in total. The outcomes I 
examined were: death by any natural cause, death by cancer, death by CVD, and death 
from all other (non-cancer/non-CVD) natural causes. The first set of models used a 
single term to differentiate lunar astronauts from all other astronauts. The other set of 
models used two binary terms to differentiate three groups of astronauts: those who 
orbited the Moon, those who walked on the Moon, and all non-lunar astronauts.
I assessed statistical significance and estimated confidence intervals around 
parameter estimates using standard errors generated from the robust sandwich 
variance estimator. This technique guards against violations of the assumption of 
the Poisson distribution that the mean is equal to the variance [36]. Significance 
testing on parameters was conducted at the α < 0.05 level.
To assess how much bias may be present in the data, I checked covariate balance 
on 4 baseline covariates between lunar and non-lunar astronauts, using standard-
ized mean differences (SMDs). Covariates with SMDs of less than 0.1 are consid-
ered to be in balance between two groups [37]. To test the statistical significance of 
the differences, I used t-tests for differences in continuous variables and chi-square 
tests with continuity correction for categorical variables. Imbalance and significant 
differences in baseline covariates may be an indicator of uncontrolled confounding 
in both measured and unmeasured variables [37].
Figure 1. 
Causal diagram for lunar astronaut mortality.
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3.2.4 Results
Table 1 displays demographic and actuarial characteristics of the lunar cohort of 
astronauts.
All of the lunar astronauts were selected to NASA between 1959 and 1966, all 
were male, and all were of White race/ethnicity. Of the 24 cohort members, 23 
of them (96%) had a military background. Twelve (50%) of the astronauts had 
a Bachelor’s degree, 10 (42%) had Master’s degrees, and 2 (8%) had Doctoral 
degrees. The average age at first lunar mission was 39.0 years, and, as of 31 
October 2018, the astronauts have been followed for an average of 41.8 years. 
Figure 2 shows the breakdown of lunar astronaut deaths by lunar mission role and 
causal category.
Half of the lunar astronauts have died (12/24). Eight of these deaths were in the 
lunar surface group, and 4 in the lunar orbit group. Of the 12 total deaths, 3 of them 
were due to cancer, 3 were due to cardiovascular disease, and the remaining 5 were 
due to other natural causes. The single death due to external causes was experienced 
by a lunar surface astronaut.
Figure 3 provides a plot of the SMDs between the full lunar cohort and the rest 
of the astronaut corps for 4 baseline covariates. The figure shows that age, year of 
selection, education, and history of military service are all unbalanced between 
lunar and non-lunar astronauts, as each of their SMD values are greater than 0.1 
(i.e., to the right of the red, vertical, dashed line). Statistical tests confirmed that 
the differences in these covariates are statistically significant, with p-values all less 
than 0.01 (values not pictured in Figure 2).
All lunar 
astronauts (N = 24)
Landed on the Moon 
(N = 12)
Orbited the Moon only 
(N = 12)
Characteristic n (%) n (%) n (%)
White 24 100.0 12 100.0 12 100
Males 24 100.0 12 100.0 12 100
Military experience 23 95.8 11 91.7 12 100
Education
Bachelor 12 50.0 5 41.7 7 58.3
Master 10 41.7 5 41.7 5 41.7
PhD 2 8.3 2 8.3 0 0.0
Mean (sd) Mean (sd) Mean (sd)
Age, years
Selection 32.8 1.9 32.6 2.2 33.0 1.6
First lunar mission 39.0 2.6 39.4 3.9 38.6 2.0
Death 73.2 13.5 78.7 9.4 64.3 16.4
End of study (survivors) 86.6 2.8 85.5 2.7 87.2 2.8
Follow-up time 41.3 11.9 41.6 10.0 41.0 14.1
Year of selection 1964 2.0 1963 2.1 1964 1.9
Year of lunar mission 1970 1.4 1970 1.4 1970 1.4
Table 1. 
Lunar cohort characteristics.
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Figure 4 displays the MRR point estimates (blue squares) and 95% confidence 
intervals (blue lines), for the age, year terms, and the lunar covariate in each of the first 
four models. Looking at the point estimates for all covariates in all models, we see that 
none of them are statistically significant predictors of mortality rate. The estimates 
attached to age were all between a 5% and 22% increase in mortality rate per additional 
year past selection. Estimates for year of selection, calendar year, and being a lunar 
astronaut were all close to 1.0 with confidence intervals that included 1.0.
Figure 5 shows the MRRs for the second set of models, in which the lunar astro-
nauts are further divided into orbital and surface subgroups. Once again age shows 
a consistent (though still statistically insignificant) increase in the mortality rate for 
all cause-of-death groups, with MRRs nearly identical to those in Figure 4.  
The point estimates for having orbited the Moon were less than 1.0 in all outcome 
models except cancer, although none of them were statistically significant. The larg-
est estimated reduction in risk for astronauts who orbited the Moon was an MRR of 
0.35 (95% CI = 0.03–3.52), for CVD.
Figure 2. 
Distribution of deaths by cause among lunar astronauts as of 31 October 2018.
Figure 3. 
Standardized mean differences (SMDs) for baseline covariates between lunar and non-lunar astronauts.
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None of the MRRs for lunar surface astronauts were statistically significant. 
However, point estimates suggest approximately double the mortality risk from 
CVD (MRR = 2.02; 95% CI = 0.55–7.36), but about two-thirds the mortality risk 
from cancer (MRR = 0.67; 95% CI = 0.08–5.90). The net effect of these mixed 
results was an MRR for all natural causes of 1.45 (95% CI = 0.56–3.70).
3.2.5 Discussion
The models presented here fail to demonstrate any statistically significant 
increase in mortality risk for lunar astronauts in comparison to non-lunar astro-
nauts. There are three potential reasons for this: (a) the models lack the statistical 
precision to discriminate excess risk from random variation; (b) the MRRs for lunar 
astronauts are confounded and thus misleading; or (c) lunar astronauts bear no 
excess mortality risk in comparison to other astronauts.
In regards to statistical precision of the models, small numbers of astronauts 
suggest, and prior studies have demonstrated poor statistical power in analyses of 
astronaut health [14, 15]. One study showed that adequate power was achieved for 
cancer mortality outcomes only when relative risks exceeded 4.0 for astronauts with 
radiation doses above the median [14]. Yet another study of 73 astronauts (including 
all 24 lunar astronauts) reported that, under reasonable assumptions about excess 
risk, statistical power was less than 6% [15]. Furthermore, power did not markedly 
improve even when assuming 10 times the number of observed deaths or 10 times 
the dose-dependent excess relative risk [15]. As statistical power is a function of 
sample size, the power of an even smaller subgroup analysis (such as lunar astro-
nauts) would be lower still. Thus, it is entirely possible that the MRRs observed 
Figure 4. 
Mortality rate ratios from Poisson models of mortality rates for all lunar astronauts.
Figure 5. 
Mortality rate ratios from Poisson models of mortality rates for orbital and surface lunar astronauts.
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here are genuine differences, but that low statistical power alone means we cannot 
reliably distinguish them from random variation.
Another consequence of small sample size is the limited ability to adjust for 
other potential confounding variables in the models of Figures 4 and 5, even when 
such variables are available. Because of this, the MRR estimates presented here may 
be confounded by other unmeasured factors that are not accounted for in the causal 
or statistical models. If so, this confounding could mask significant differences in 
mortality risk between lunar and non-lunar astronauts. Figure 3 provides evidence 
of differences between lunar and non-lunar astronauts on at least 4 measured 
covariates, which may be evidence of confounding. Furthermore, the causal dia-
gram of Figure 1 suggests more unobserved confounding is possible. Of particular 
concern are unmeasured lifestyle factors such as tobacco use, alcohol use, diet, and 
exercise.
Though it is possible that low statistical precision or confounding is obscuring 
increased risk for lunar astronauts, it nevertheless seems implausible given the small 
exposure the lunar astronauts had to the major hazards of the lunar  environment – 
hypogravity, cosmic radiation, and lunar dust. Specifically:
a. The total time of exposure to hypogravity for lunar astronauts pales in com-
parison to astronauts who have completed multiple shuttle missions or long-
duration stays on the ISS. The mean time in space for lunar astronauts was 
18.7 days, whereas the mean time in space for non-lunar astronauts (among 
those who have been to space) is 76.8 days. The average mission time for lunar 
astronauts was 8.7 days accrued on an average of 2 missions, while the average 
mission time for non-lunar astronauts was 26.1 days accrued on an average 
of 3 missions each. So, if exposure to hypogravity creates excess mortality 
risk – either in relation to total exposure time or unique number of exposures 
– non-lunar astronauts should be at greater risk than lunar astronauts. This is 
especially true if 0 G is more deleterious than lunar gravity, since the entirety 
of hypogravity exposure for non-lunar LEO astronauts has been in 0 G.
b. The doses of ionizing space radiation received by lunar astronauts are not 
extreme among astronauts or in comparison to Earth-based radiation work-
ers. For example, as of 1993, lifetime cosmic radiation doses received by all 
astronauts, lunar included, were noted to be smaller than those received from 
medical diagnostic doses, [38] while a more recent report notes that only a 
third of the astronauts selected before 1970 received total space radiation doses 
greater than 11 mGy [33]. It should be noted that with the doses of space radia-
tion received by all astronauts to date – even among those at the highest end 
of absorbed dose – that no acute effects have been observed, and only mildly 
increased risk of minor late effects has been observed [39, 40].
Furthermore, the doses received by lunar astronauts would have to exceed 
those of non-lunar astronauts in order for lunar astronauts to be observed as at 
greater radiation-induced risk of mortality. Radiation dose is highly correlated 
with time in space, so just as non-lunar astronauts have logged considerably 
more time in space, they also have larger doses of cosmic radiation. Were 
cosmic radiation doses in the astronaut cohort as a whole at harmful levels 
we might therefore expect to see lunar astronauts at reduced mortality risk in 
comparison to non-lunar astronauts.
c. Though lunar dust is known to be more toxic than most dust found in industrial 
settings on earth, the astronauts’ exposure to it was limited in both intensity and 
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duration. Exposure to lunar dust was isolated, with direct contact limited to the 
time at rest in the lunar module and the trip back to earth in the command and 
service modules. All told this would equate to mere days of exposure at most. 
Workers on Earth who develop pneumoconiosis and other respiratory diseases 
typically only do so after repeated, sustained exposure to dust [26]. Based on 
what is known about dust exposure for workers on Earth, such brief exposure to 
lunar dust would therefore be unlikely to cause any lasting health problems, and 
thus unlikely to be a source of increased mortality for lunar astronauts.
In short, the exposures faced by lunar astronauts, though almost certainly harm-
ful in sufficient quantity, were likely of inadequate intensity and duration to cause 
long-term excess mortality risk on historic missions.
4. Conclusions
The lunar environment poses a number of health risks for human explorers, 
some exotic and some familiar. Chief among them are hypobaric environments, 
hypogravity, cosmic radiation, and lunar dust. All of these, in sufficient doses, have 
the potential to cause a number of deleterious health effects.
The risk of hypobaric injury and death from the lack of atmosphere is omni-
present for astronauts living and working on the Moon. Deconditioning of the 
cardiovascular system in microgravity is a well-known hazard which is likely only 
partially abated by the Moon’s low-gravity environment. Without appropriate pro-
tection, the radiation environment on the Moon is capable of producing an array of 
both acute and chronic health problems. Finally, lunar dust, as a highly fragmented 
and highly reactive substance, has the potential to cause respiratory illness, which 
may be exacerbated by differential patterns of particle deposition in the lungs under 
hypogravity conditions.
There have been only 24 individuals who have thus far visited the Moon, and to 
date they have shown no evidence of increased mortality rates for having done so. 
Yet, because of the small size of the cohort, it is possible that moderate increases 
in mortality risk from some causes may be in play. It is also possible that mortality 
estimates are confounded by uncontrolled factors. However, it seems unlikely that 
lunar astronauts are subject to excess mortality risk in comparison to non-lunar 
astronauts as a result of lunar missions. The duration of exposure to hypogravity 
and dose of cosmic radiation were low in comparison to non-lunar astronauts. 
Lunar astronauts’ exposure to lunar dust was episodic and likely below the exposure 
threshold needed to trigger respiratory disease and thus increased mortality risk.
Though humanity currently has little direct experience with the lunar environ-
ment, our knowledge will continue to grow as humans return to the Moon in the 
decades to come. What we learn about how to successfully colonize the Moon will 
teach us valuable lessons that will allow us to colonize Mars and beyond. It thus 
becomes critical to continue to study human health in extraterrestrial environ-
ments, learning what we can as we can. The small steps of such ongoing efforts will 
thus enable the giant leaps that follow.
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